Announcement on renewing the employment of an accounting firm for 2024
Announcement on daily related transactions in 2024
Announcement on the intention of the company and its wholly-owned subsidiaries to apply for comprehensive credit lines from various banks in 2024
Announcement on the intention to transfer 92% of the shares of the holding subsidiary Golden Sun Pharmaceutical through public listing
Announcement on the company's transfer of land use rights and completion of related transactions
2023 Annual Report Summary
2023 ANNUAL REPORT
2023 Audit Report
Special explanation on the occupation of non-operating capital and other related capital transactions in 2023
2023 Internal Control Evaluation Report
Special Report of the Board of Directors on the Deposit and Use of Funds Raised in 2023
2023 Fund Raised Fund Deposit and Use Verification Report
2023 Internal Control Audit Report
Special Audit Report on the 2023 Operating Income Deduction Status
Guoyuan Securities Co., Ltd.'s special inspection report on the storage and actual use of funds raised by Golden Seed Liquor in 2023
2023 Audit Committee Performance Report
Evaluation report on the performance of accounting firms in 2023
Special report of the board of directors on the 2023 independence self-inspection of independent directors
2023 Internal Control Audit Report
2023 Independent Director Debriefing Report (Fan Yong)
No Data